NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that William Prather RPh, MD, Pluristem’s Senior Vice President for Corporate Development, has been invited to be a featured speaker at “The Stem Cell Network” conference. The title of the conference is “Stem Cell Therapy – The Future of Medicine” and it will be held on March 19, 2009 at the Marriot Del Mar Hotel in San Diego, California. Dr. Prather will present an overview of Pluristem and an update on the clinical development of the Company’s placental-derived (PLX) stem cells. Other featured speakers at the event include Robert Klein JD, Chairman of the Governing Board of the California Institute of Regenerative Medicine and Robert Harman DVM, CEO of Vet Stem, Inc.
